IRS 19 - complex immunostimulatory drug with properties topical vaccine, used to prevent and treat bronchitis, rhinitis, laryngitis, pharyngitis, and other acute and chronic diseases of the upper respiratory tract and bronchi. Widely used in pediatrics.
Irs 19 belongs to the group of antibacterial vaccines. Active substances - bacterial lysates, which are the most common causative agents of respiratory infections.
When lysis (destruction) of the bacteria retained the characteristics of each strain that allows you to develop a specific and non-specific protective immunity.
When spraying a preparation covering the nasal mucosa than secures the airway. It acts almost immediately, in a few minutes after administration. The protective effect lasts up to two hours. After two weeks of IRS 19 on the surface of the mucous forms a reliable barrier, which lasts for 3-4 months.
The drug is well tolerated, it is administered to infants between the ages of three months.
IRS 19 is produced in the form of a clear, colorless nasal spray with a weak smell.
100 ml of the product contained 43.27 mL of bacterial lysates:
- Streptococcus pneumoniae - type I, II, III, V, VIII, XII;
- Acinetobacter calcoaceticus;
- Staphylococcus aureus ss aureus;
- Neisseria subflava, Neisseria perflava;
- Streptococcus group A, C, G;
- Enterococcus faecium, Enterococcus faecalis.
- Moraxella catarrhalis;
- Klebsiella pneumoniae ss pneumoniae;
- Haemophilus influenzae type B.
The glass aerosol bottles of 20 ml - with a nozzle and a continuous valve, in a carton box.
Indications Irs 19
IRS 19 on instructions used in:
- The trachea;
Also according to the instructions IRS 19 is used for the prevention of these diseases, for immune reconstitution after suffering a variety of viral infections, and in preparation for surgery on ENT.
In the opinion of IRS 19 is sufficiently effective for both adults and children, including infants.
A preparation according to instructions virtually no contraindications, except:
- Increased sensitivity to the IRS 19 and its components;
- Autoimmune diseases.
Instructions for use IRS 19
IRS 19 for instructions used intranasally - briefly pressing spray. Depending on the disease and the age of the different treatment regimens used.
IRS 19 children from three months old to 3 years for the treatment of diseases of the bronchi and upper respiratory tract appoint one dose each nostril 2 times a day and older children and adults - from 2 to 5 times a day. In the opinion of IRS 19 is effective when the pre-cleaned prior to use his nose. The course continued until symptoms of infection.
After diseases to restore immunity Irs 19 appoint one dose of the drug 2 times a day in each nostril for two weeks.
In the same course prescribed Irs 19 children and adults for the prevention of infectious diseases, preferably a few weeks before a possible increase in morbidity, and a week in preparation for the planned rapid intervention.
Early treatment can worsen nasal discharge and sneezing, which, in the opinion of the IRS 19 passes quickly. In case of more severe reactions to the drug can reduce the number of receptions or cancel it.
IRS 19 can simultaneously be used for the combined vaccination with influenza vaccine.
In the treatment of the drug:
- Stops infectious process at the beginning of the disease;
- It allows you to reduce the number of days of antibiotics or anti-inflammatory drugs;
- Accelerates recovery;
- Significantly reduces the risk of complications.
While the use of intranasal vasoconstrictor drops Irs 19 for stimulation of immunity should be applied half an hour after them.
- The nozzle for an aerosol container, which should be in the center and push it without effort;
- The bottle should be kept at-spraying vertically, as you can not throw back his head to avoid damage to the bottle;
- If the drug is used regularly, the nozzle should not be removed;
- If the drug has remained a long time without application of liquid crystals formed may clog the hole. When plugging should make a few clicks and rinse with warm water nozzle.
IRS 19 children and adults is well tolerated.
Sometimes during treatment may occur angioneurotic edema, cough, rash, abdominal pain, nausea and fever for no apparent reason.
Cases of negative interaction IRS 19 with other drugs as part of combination therapy are unknown. Cases of overdose have not been described.
The chemical composition and mechanism of action unique IRS 19 among domestic and foreign drugs are not allowed. Quite often use a variety of other drugs, which have an immunomodulatory and anti-inflammatory effect.
These include Broncho-moon, Broncho-munal P, Imudon, bacterial lysates mixture and Interferon. However, to attribute them to peers Irs 19 only mechanism of action.
IRS 19 is available without prescription. Shelf life - 3 years.